BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of marker genes starting with is 271
| GENE | HGNC_ID | CANCER_TYPE | HISTOLOGICAL_TYPE | CSC_ENRICHMENT | METHOD | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|
| NANOG | 20857 | Lung Cancer | Adenocarcinoma | NA | IHC staining and IF staining followed by qRT-PCR | 0.92 | 0.5461 | 31894290 |
| NANOG | 20857 | Lung Cancer | NA | NA | IHC staining | 0.92 | 0.5461 | 32500024 |
| NANOG | 20857 | Lung Cancer | Adenocarcinoma | NA | qRT-PCR | 0.92 | 0.5461 | 21159654 |
| NANOG | 20857 | Lung Cancer | NA | NA | RT-PCR | 0.92 | 0.5461 | 24018162 |
| NANOG | 20857 | Lung Cancer | Squamous Cell Carcinoma | NA | RT-PCR | 0.92 | 0.5461 | 27698819 |
| NANOG | 20857 | Lung Cancer | Adenocarcinoma | Erlotinib | RT-PCR followed by SFA | 0.92 | 0.5461 | 28347243 |
| NANOG | 20857 | Lung Cancer | NA | NA | SFA and IF staining | 0.92 | 0.5461 | 33531664 |
| NANOG | 20857 | Lung Cancer | NA | PD98059 | SFA followed by qRT-PCR | 0.92 | 0.5461 | 33867839 |
| POU5F1 | 9221 | Lung Cancer | Adenocarcinoma | NA | IHC staining and IF staining followed by qRT-PCR | 0.92 | 0.6448 | 31894290 |
| POU5F1 | 9221 | Lung Cancer | Adenocarcinoma | NA | SP assay and Western Blotting followed by RT-PCR and SFA | 0.92 | 0.6448 | 26416062 |
| POU5F1 | 9221 | Lung Cancer | Adenocarcinoma | NA | SP assay followed by qRT-PCR and Western Blotting | 0.92 | 0.6448 | 22285547 |
| POU5F1 | 9221 | Lung Cancer | NA | NA | IHC staining | 0.92 | 0.6448 | 32500024 |
| POU5F1 | 9221 | Lung Cancer | NA | NA | SFA followed by IF staining | 0.92 | 0.6448 | 25955492 |
| POU5F1 | 9221 | Lung Cancer | NA | NA | SFA followed by IF staining | 0.92 | 0.6448 | 25955492 |
| POU5F1 | 9221 | Lung Cancer | Adenocarcinoma | NA | qRT-PCR | 0.92 | 0.6448 | 21159654 |
| POU5F1 | 9221 | Lung Cancer | NA | NA | RT-PCR | 0.92 | 0.6448 | 19536353 |
| POU5F1 | 9221 | Lung Cancer | NA | NA | SFA followed by RT-PCR | 0.92 | 0.6448 | 24019906 |
| SOX2 | 11195 | Lung Cancer | Adenocarcinoma | NA | IHC staining and IF staining followed by qRT-PCR | 0.92 | 0.5695 | 31894290 |
| SOX2 | 11195 | Lung Cancer | Adenocarcinoma | NA | SP assay followed by qRT-PCR and Western Blotting | 0.92 | 0.5695 | 22285547 |
| SOX2 | 11195 | Lung Cancer | NA | NA | IHC staining | 0.92 | 0.5695 | 32500024 |
| SOX2 | 11195 | Lung Cancer | NA | PD98059 | SFA followed by qRT-PCR | 0.92 | 0.5695 | 33867839 |
| ALDH1A1 | 402 | Lung Cancer | Adenocarcinoma | NA | SFA and FACs followed by IHC staining and IF staining | 0.84 | 0.684 | 28855609 |
| ALDH1A1 | 402 | Lung Cancer | NA | NA | FACs followed by IHC staining | 0.84 | 0.684 | 32500024 |
| ALDH1A1 | 402 | Lung Cancer | NA | NA | IHC staining followed by ALDEFLUOR assay | 0.84 | 0.684 | 19536353 |
| ALDH1A1 | 402 | Lung Cancer | Adenocarcinoma | NA | SFA followed by ALDEFLUOR assay and qPCR | 0.84 | 0.684 | 26621583 |
| ALDH1A1 | 402 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.84 | 0.684 | 23252868 |
| ALDH1A1 | 402 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.84 | 0.684 | 24235845 |
| ALDH1A1 | 402 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.84 | 0.684 | 26046383 |
| ALDH1A1 | 402 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.84 | 0.684 | 28476825 |
| ALDH1A1 | 402 | Lung Cancer | Carcinoma | NA | IHC staining | 0.84 | 0.684 | 30303135 |
| ALDH1A1 | 402 | Lung Cancer | NA | NA | SFA followed by IF staining | 0.84 | 0.684 | 25955492 |
| ALDH1A1 | 402 | Lung Cancer | Adenocarcinoma | Erlotinib | RT-PCR followed by SFA | 0.84 | 0.684 | 28347243 |
| ALDH1A1 | 402 | Lung Cancer | NA | PD98059 | SFA followed by qRT-PCR | 0.84 | 0.684 | 33867839 |
| ALDH1A1 | 402 | Lung Cancer | NA | NA | ALDEFLUOR assay | 0.84 | 0.684 | 31930020 |
| ALDH1A1 | 402 | Lung Cancer | NA | NA | FACs followed by SFA | 0.84 | 0.684 | 32391123 |
| ALDH1A1 | 402 | Lung Cancer | Adenocarcinoma | NA | SFA and Tumorigenicity assay followed by ALDEFLUOR assay | 0.84 | 0.684 | 25034785 |
| ALDH1A1 | 402 | Lung Cancer | Large Cell Neuroendocrine Carcinoma | NA | SFA and Tumorigenicity assay followed by ALDEFLUOR assay | 0.84 | 0.684 | 25034785 |
| ALDH1A1 | 402 | Lung Cancer | Squamous Cell Carcinoma | NA | SFA and Tumorigenicity assay followed by ALDEFLUOR assay | 0.84 | 0.684 | 25034785 |
| ALCAM | 400 | Non Small Cell Lung Cancer | NA | NA | IHC staining followed by Western Blotting | 0.68 | 0.0583 | 24501004 |
| ALCAM | 400 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.68 | 0.0583 | 24346092 |
| ALCAM | 400 | Non Small Cell Lung Cancer | NA | NA | qRT-PCR followed by SFA | 0.68 | 0.0583 | 29568370 |
| ALCAM | 400 | Non Small Cell Lung Cancer | NA | NA | FACs followed by SFA | 0.68 | 0.0583 | 22225612 |
| ALCAM | 400 | Non Small Cell Lung Cancer | NA | NA | FACs followed by SFA and Tumorigenicity assay | 0.68 | 0.0583 | 26846105 |
| ALCAM | 400 | Non Small Cell Lung Cancer | NA | NA | SFA followed by FACs | 0.68 | 0.0583 | 28416482 |
| ALCAM | 400 | Non Small Cell Lung Cancer | NA | NA | SFA followed by FACs and Tumorigenicity assay | 0.68 | 0.0583 | 26513225 |
| CD44 | 1681 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by IF staining and Western Blotting | 0.68 | 1 | 31506430 |
| CD44 | 1681 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.68 | 1 | 33036771 |
| CD44 | 1681 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.68 | 1 | 24346092 |
| CD44 | 1681 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.68 | 1 | 33109579 |
| CD44 | 1681 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.68 | 1 | 33925297 |
| CD44 | 1681 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by IF staining | 0.68 | 1 | 33925297 |
| CD44 | 1681 | Non Small Cell Lung Cancer | NA | NA | qRT-PCR followed by SFA | 0.68 | 1 | 29568370 |
| CD44 | 1681 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.68 | 1 | 31506430 |
| CD44 | 1681 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs | 0.68 | 1 | 34277782 |
| CD44 | 1681 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.68 | 1 | 19464919 |
| CD44 | 1681 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.68 | 1 | 22225612 |
| CD44 | 1681 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs | 0.68 | 1 | 31921651 |
| CD44 | 1681 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | FACs | 0.68 | 1 | 31921651 |
| CD44 | 1681 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by FACs | 0.68 | 1 | 27343631 |
| CD44 | 1681 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.68 | 1 | 27343631 |
| NANOG | 20857 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by IF staining and Western Blotting | 0.68 | 0.5461 | 31506430 |
| NANOG | 20857 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | RT-PCR | 0.68 | 0.5461 | 31921651 |
| NANOG | 20857 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | RT-PCR | 0.68 | 0.5461 | 31921651 |
| NANOG | 20857 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.68 | 0.5461 | 33036771 |
| NANOG | 20857 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | qRT-PCR followed by SFA | 0.68 | 0.5461 | 28855609 |
| ABCG2 | 74 | Lung Cancer | Adenocarcinoma | NA | SP assay and Western Blotting followed by RT-PCR and SFA | 0.64 | 0.1739 | 26416062 |
| ABCG2 | 74 | Lung Cancer | NA | NA | FACs followed by SFA | 0.64 | 0.1739 | 34929442 |
| FSCN1 | 11148 | Lung Cancer | Adenocarcinoma | NA | SP assay followed by qRT-PCR and Western Blotting | 0.64 | 0.0064 | 22285547 |
| NES | 7756 | Non Small Cell Lung Cancer | NA | NA | IHC staining followed by IF staining | 0.64 | 0.0573 | 21293543 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IHC staining followed by IF staining | 0.64 | 0.7582 | 21293543 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IHC staining followed by qRT-PCR | 0.64 | 0.7582 | 26770215 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | SFA followed by FACs and Western Blotting | 0.64 | 0.7582 | 32552834 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IHC staining and FACs followed by SFA and Tumorigenicity assay | 0.64 | 0.7582 | 18049477 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | Cisplatin | IHC staining followed by FACs and Tumorigenicity assay | 0.64 | 0.7582 | 19805294 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | MACs and FACs followed by SFA | 0.64 | 0.7582 | 21225866 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | MACs and FACs followed by SFA | 0.64 | 0.7582 | 21225866 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IF staining | 0.64 | 0.7582 | 25806288 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.64 | 0.7582 | 22115706 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.64 | 0.7582 | 22199321 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.64 | 0.7582 | 23878161 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.64 | 0.7582 | 24346092 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.64 | 0.7582 | 29158791 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IHC staining followed by Tumorigenicity assay | 0.64 | 0.7582 | 19676044 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | qRT-PCR followed by SFA | 0.64 | 0.7582 | 29568370 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.64 | 0.7582 | 19464919 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.64 | 0.7582 | 22225612 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | MACs followed by SFA and Tumorigenicity assay | 0.64 | 0.7582 | 18612434 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | MACs followed by SFA and Tumorigenicity assay | 0.64 | 0.7582 | 18612434 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by FACs | 0.64 | 0.7582 | 27343631 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.64 | 0.7582 | 27343631 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs followed by qRT-PCR and SFA | 0.64 | 0.7582 | 28855609 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | IF staining | 0.64 | 0.7582 | 33894494 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | IF staining | 0.64 | 0.7582 | 27920206 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.64 | 0.7582 | 33925297 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by IF staining | 0.64 | 0.7582 | 33925297 |
| PROM1 | 9454 | Non Small Cell Lung Cancer | NA | NA | SFA followed by FACs | 0.64 | 0.7582 | 28416482 |
| SCD | 10571 | Non Small Cell Lung Cancer | NA | NA | SFA followed by RT-PCR and Western Blotting | 0.64 | 0.0127 | 24309934 |
| SH2D3A | 16885 | Lung Cancer | NA | NA | qRT-PCR and Western Blotting followed by SFA | 0.64 | 0.0021 | 34385181 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | IHC staining followed by qRT-PCR | 0.6 | 0.684 | 26770215 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | qRT-PCR followed by IHC staining | 0.6 | 0.684 | 25881507 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | ALDEFLUOR assay followed by IHC staining | 0.6 | 0.684 | 31921651 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay followed by IHC staining | 0.6 | 0.684 | 31921651 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs followed by qRT-PCR and SFA | 0.6 | 0.684 | 28855609 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | IF staining | 0.6 | 0.684 | 27920206 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.6 | 0.684 | 33036771 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.6 | 0.684 | 22115706 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.6 | 0.684 | 23878161 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.6 | 0.684 | 24346092 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | qRT-PCR followed by SFA | 0.6 | 0.684 | 29568370 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.6 | 0.684 | 28416482 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.6 | 0.684 | 31506430 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | ALDEFLUOR assay | 0.6 | 0.684 | 33868998 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | ALDEFLUOR assay followed by CFA and Tumorigenicity assay | 0.6 | 0.684 | 30305380 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | NA | NA | ALDEFLUOR assay followed by SFA | 0.6 | 0.684 | 24309934 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by ALDEFLUOR assay | 0.6 | 0.684 | 27343631 |
| ALDH1A1 | 402 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | SFA followed by ALDEFLUOR assay | 0.6 | 0.684 | 27343631 |
| LGR5 | 4504 | Non Small Cell Lung Cancer | NA | NA | qRT-PCR followed by IHC staining | 0.6 | 0.0753 | 25881507 |
| LGR5 | 4504 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.6 | 0.0753 | 33109579 |
| ABCB1 | 40 | Lung Cancer | NA | NA | IHC staining followed by FACs | 0.52 | 0.0604 | 19536353 |
| CD24 | 1645 | Small Cell Lung Cancer | NA | NA | IF staining followed by FACs | 0.52 | 0.456 | 31446534 |
| CD44 | 1681 | Lung Cancer | NA | NA | IHC staining followed by FACs | 0.52 | 1 | 19536353 |
| CD44 | 1681 | Lung Cancer | Adenocarcinoma | NA | SFA followed by FACs and qPCR | 0.52 | 1 | 26621583 |
| CD44 | 1681 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 1 | 23252868 |
| CD44 | 1681 | Lung Cancer | NA | NA | IHC staining | 0.52 | 1 | 25335738 |
| CD44 | 1681 | Lung Cancer | Carcinoma | NA | IHC staining | 0.52 | 1 | 28286162 |
| CD44 | 1681 | Lung Cancer | NA | NA | SFA and IF staining | 0.52 | 1 | 33531664 |
| CD44 | 1681 | Lung Cancer | Squamous Cell Carcinoma | NA | RT-PCR | 0.52 | 1 | 27698819 |
| CD44 | 1681 | Lung Cancer | Adenocarcinoma | NA | FACs followed by CFA | 0.52 | 1 | 33135338 |
| CD44 | 1681 | Lung Cancer | Adenocarcinoma | Erlotinib | FACs followed by SFA | 0.52 | 1 | 28347243 |
| CD44 | 1681 | Lung Cancer | NA | NA | FACs followed by SFA | 0.52 | 1 | 32391123 |
| CD44 | 1681 | Lung Cancer | Adenocarcinoma | NA | SFA followed by FACs | 0.52 | 1 | 29720480 |
| CD44 | 1681 | Lung Cancer | NA | NA | SFA followed by FACs and Tumorigenicity assay | 0.52 | 1 | 24019906 |
| CD44 | 1681 | Small Cell Lung Cancer | NA | NA | IF staining followed by FACs | 0.52 | 1 | 31446534 |
| CD44 | 1681 | Small Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.52 | 1 | 25963795 |
| CD44 | 1681 | Small Cell Lung Cancer | NA | NA | IHC staining | 0.52 | 1 | 27363902 |
| MET | 7029 | Lung Cancer | NA | NA | IHC staining followed by FACs | 0.52 | 0.0191 | 19536353 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | SFA and FACs followed by IHC staining | 0.52 | 0.7582 | 28855609 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | SFA followed by FACs and qPCR | 0.52 | 0.7582 | 26621583 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | MACs followed by FACs and SFA | 0.52 | 0.7582 | 25435932 |
| PROM1 | 9454 | Lung Cancer | NA | Cisplatin | IHC staining | 0.52 | 0.7582 | 19805294 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 0.7582 | 23252868 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 0.7582 | 26046383 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 0.7582 | 28476825 |
| PROM1 | 9454 | Lung Cancer | NA | NA | SFA followed by IF staining | 0.52 | 0.7582 | 25955492 |
| PROM1 | 9454 | Lung Cancer | NA | NA | FACs | 0.52 | 0.7582 | 30397852 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | FACs followed by CFA | 0.52 | 0.7582 | 33135338 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | MACs followed by SFA and Tumorigenicity assay | 0.52 | 0.7582 | 25738369 |
| PROM1 | 9454 | Lung Cancer | Large Cell Neuroendocrine Carcinoma | NA | SFA and Tumorigenicity assay followed by FACs | 0.52 | 0.7582 | 25034785 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | SFA and Tumorigenicity assay followed by FACs | 0.52 | 0.7582 | 25034785 |
| PROM1 | 9454 | Lung Cancer | Squamous Cell Carcinoma | NA | SFA and Tumorigenicity assay followed by FACs | 0.52 | 0.7582 | 25034785 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | SFA followed by FACs | 0.52 | 0.7582 | 29720480 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | SP assay followed by FACs and SFA | 0.52 | 0.7582 | 22285547 |
| PROM1 | 9454 | Small Cell Lung Cancer | NA | NA | IF staining followed by FACs | 0.52 | 0.7582 | 31446534 |
| PROM1 | 9454 | Small Cell Lung Cancer | NA | NA | IHC staining and FACs followed by SFA and Tumorigenicity assay | 0.52 | 0.7582 | 18049477 |
| PROM1 | 9454 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.52 | 0.7582 | 34803670 |
| PROM1 | 9454 | Lung Cancer | NA | PD98059 | SFA followed by qRT-PCR | 0.52 | 0.7582 | 33867839 |
| PROM1 | 9454 | Lung Cancer | NA | NA | FACs followed by SFA | 0.52 | 0.7582 | 34929442 |
| CD44 | 1681 | Large Cell Lung Cancer | Carcinoma | NA | Proteomics followed by IHC staining | 0.48 | 1 | 21888658 |
| CD44 | 1681 | Large Cell Lung Cancer | Carcinoma | NA | Proteomics followed by IHC staining | 0.48 | 1 | 21888658 |
| ALCAM | 400 | Lung Cancer | Adenocarcinoma | NA | SFA followed by FACs and qPCR | 0.48 | 0.0583 | 26621583 |
| ALCAM | 400 | Lung Cancer | NA | NA | SFA followed by IF staining | 0.48 | 0.0583 | 25955492 |
| CD44 | 1681 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.48 | 1 | 25963795 |
| CD44 | 1681 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.48 | 1 | 25963795 |
| EPCAM | 11529 | Lung Cancer | Adenocarcinoma | NA | SFA followed by FACs and qPCR | 0.48 | 0.211 | 26621583 |
| EPCAM | 11529 | Lung Cancer | NA | NA | FACs | 0.48 | 0.211 | 30397852 |
| EPCAM | 11529 | Lung Cancer | Adenocarcinoma | Erlotinib | FACs followed by SFA | 0.48 | 0.211 | 28347243 |
| EPCAM | 11529 | Lung Cancer | NA | NA | FACs followed by SFA | 0.48 | 0.211 | 32391123 |
| EPCAM | 11529 | Lung Cancer | Adenocarcinoma | NA | SFA and FACs | 0.48 | 0.211 | 28855609 |
| ABCG2 | 74 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | MACs followed by FACs and Migration assay | 0.4 | 0.1739 | 18612434 |
| ABCG2 | 74 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | MACs followed by FACs and Migration assay | 0.4 | 0.1739 | 18612434 |
| ABCG2 | 74 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.4 | 0.1739 | 22199321 |
| CTNNB1 | 2514 | Lung Cancer | Adenocarcinoma | NA | SP assay and Western Blotting followed by SFA | 0.4 | 0.0647 | 26416062 |
| CTNNB1 | 2514 | Lung Cancer | Adenocarcinoma | NA | IHC staining | 0.4 | 0.0647 | 23252868 |
| LIN28A | 15986 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs for CSC marker followed by Western Blotting | 0.36 | 0.0138 | 34277782 |
| ABCG5 | 13886 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.0021 | 24346092 |
| ALCAM | 400 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0583 | 25963795 |
| ALCAM | 400 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0583 | 25963795 |
| ALCAM | 400 | Small Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0583 | 25963795 |
| ALDH1A1 | 402 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.684 | 25963795 |
| ALDH1A1 | 402 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.684 | 25963795 |
| ALDH1A1 | 402 | Small Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.684 | 25963795 |
| BHLHA15 | 22265 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.0021 | 33109579 |
| CAV1 | 1527 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0117 | 25963795 |
| CAV1 | 1527 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0117 | 25963795 |
| CAV1 | 1527 | Small Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0117 | 25963795 |
| CD24 | 1645 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.456 | 24346092 |
| CD24 | 1645 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs | 0.32 | 0.456 | 34277782 |
| DRD2 | 3023 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | IF staining | 0.32 | 0.0011 | 27920206 |
| FZD7 | 4045 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.0064 | 33109579 |
| GLI1 | 4317 | Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0308 | 28286162 |
| KDM1A | 29079 | Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0021 | 28286162 |
| KIT | 6342 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.018 | 22199321 |
| KIT | 6342 | Non Small Cell Lung Cancer | Large Cell Neuroendocrine Carcinoma | NA | SFA and Tumorigenicity assay followed by FACs | 0.32 | 0.018 | 25034785 |
| MSI1 | 7330 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0201 | 25963795 |
| MSI1 | 7330 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0201 | 25963795 |
| MSI1 | 7330 | Small Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0201 | 25963795 |
| MYC | 7553 | Lung Cancer | NA | NA | IHC staining | 0.32 | 0.1304 | 32500024 |
| NES | 7756 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.32 | 0.0573 | 33925297 |
| NES | 7756 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by IF staining | 0.32 | 0.0573 | 33925297 |
| NOTCH1 | 7881 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0477 | 25963795 |
| NOTCH1 | 7881 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0477 | 25963795 |
| NOTCH1 | 7881 | Small Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0477 | 25963795 |
| POU5F1 | 9221 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.6448 | 22300949 |
| POU5F1 | 9221 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.6448 | 24346092 |
| POU5F1 | 9221 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.6448 | 29158791 |
| POU5F1 | 9221 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | qRT-PCR followed by SFA | 0.32 | 0.6448 | 28855609 |
| REL | 9954 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.32 | 0.0021 | 33925297 |
| REL | 9954 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by IF staining | 0.32 | 0.0021 | 33925297 |
| RELA | 9955 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.32 | 0.0032 | 33925297 |
| RELA | 9955 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by IF staining | 0.32 | 0.0032 | 33925297 |
| RELB | 9956 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.32 | 0.0032 | 33925297 |
| RELB | 9956 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | SFA followed by IF staining | 0.32 | 0.0032 | 33925297 |
| SOX2 | 11195 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.5695 | 25963795 |
| SOX2 | 11195 | Large Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.5695 | 25963795 |
| SOX2 | 11195 | Non Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.5695 | 24346092 |
| SOX2 | 11195 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | qRT-PCR followed by SFA | 0.32 | 0.5695 | 28855609 |
| SOX2 | 11195 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | RT-PCR | 0.32 | 0.5695 | 31921651 |
| SOX2 | 11195 | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | NA | RT-PCR | 0.32 | 0.5695 | 31921651 |
| SOX2 | 11195 | Small Cell Lung Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.5695 | 25963795 |
| SOX2 | 11195 | Small Cell Lung Cancer | NA | NA | IHC staining | 0.32 | 0.5695 | 27363902 |
| THY1 | 11801 | Lung Cancer | NA | NA | SFA followed by IF staining | 0.32 | 0.0371 | 25955492 |
| BMI1 | 1066 | Lung Cancer | NA | NA | RT-PCR | 0.28 | 0.1135 | 19536353 |
| BMI1 | 1066 | Lung Cancer | Adenocarcinoma | Erlotinib | RT-PCR followed by SFA | 0.28 | 0.1135 | 28347243 |
| BMI1 | 1066 | Lung Cancer | NA | NA | SFA followed by RT-PCR | 0.28 | 0.1135 | 24019906 |
| BMI1 | 1066 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.1135 | 28416482 |
| CCND1 | 1582 | Lung Cancer | Adenocarcinoma | NA | SP assay and RT-PCR followed by SFA | 0.28 | 0.0201 | 26416062 |
| CDKN1A | 1784 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0042 | 31506430 |
| CTNNB1 | 2514 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0647 | 31506430 |
| CTNNB1 | 2514 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0647 | 28416482 |
| DLL4 | 2910 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0042 | 31506430 |
| EZH2 | 3527 | Lung Cancer | NA | NA | RT-PCR | 0.28 | 0.0074 | 19536353 |
| GLDC | 4313 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0021 | 28416482 |
| GSK3B | 4617 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0053 | 31506430 |
| ITGA6 | 6142 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0265 | 31506430 |
| ITGA6 | 6142 | Non Small Cell Lung Cancer | NA | NA | FACs followed by SFA | 0.28 | 0.0265 | 28416482 |
| ITGA6 | 6142 | Non Small Cell Lung Cancer | NA | NA | SFA followed by FACs | 0.28 | 0.0265 | 28416482 |
| JAG1 | 6188 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0117 | 31506430 |
| JUNB | 6205 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0021 | 31506430 |
| KLF4 | 6348 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0891 | 31506430 |
| LIN28B | 32207 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0032 | 28416482 |
| MDM2 | 6973 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0042 | 31506430 |
| MIRLET7C | 31480 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs for CSC marker followed by qRT-PCR | 0.28 | 0.0042 | 34277782 |
| MIRLET7F1 | 31483 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs for CSC marker followed by qRT-PCR | 0.28 | 0.0053 | 34277782 |
| MIRLET7G | 31485 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs for CSC marker followed by qRT-PCR | 0.28 | 0.0032 | 34277782 |
| MMP9 | 7176 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0021 | 31506430 |
| MYC | 7553 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.1304 | 28416482 |
| NOTCH1 | 7881 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0477 | 31506430 |
| NOTCH3 | 7883 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0085 | 31506430 |
| PTEN | 9588 | Lung Cancer | NA | NA | RT-PCR | 0.28 | 0.0053 | 19536353 |
| SNAI1 | 11128 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0212 | 31506430 |
| SUZ12 | 17101 | Lung Cancer | NA | NA | RT-PCR | 0.28 | 0.0032 | 19536353 |
| SUZ12 | 17101 | Lung Cancer | NA | NA | SFA followed by RT-PCR | 0.28 | 0.0032 | 24019906 |
| TERT | 11730 | Lung Cancer | NA | NA | RT-PCR | 0.28 | 0.0053 | 19536353 |
| TERT | 11730 | Lung Cancer | NA | NA | SFA followed by RT-PCR | 0.28 | 0.0053 | 24019906 |
| TGFB1 | 11766 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0138 | 28416482 |
| THY1 | 11801 | Non Small Cell Lung Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0371 | 31506430 |
| CD24 | 1645 | Lung Cancer | Adenocarcinoma | NA | FACs followed by CFA | 0.2 | 0.456 | 33135338 |
| CD24 | 1645 | Lung Cancer | Adenocarcinoma | Erlotinib | FACs followed by SFA | 0.2 | 0.456 | 28347243 |
| CD274 | 17635 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.2 | 0.0032 | 32808188 |
| CD274 | 17635 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.2 | 0.0032 | 32808188 |
| EPCAM | 11529 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.2 | 0.211 | 19464919 |
| EPCAM | 11529 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.2 | 0.211 | 19805294 |
| EPCAM | 11529 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.2 | 0.211 | 22225612 |
| EPCAM | 11529 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs | 0.2 | 0.211 | 34277782 |
| EPCAM | 11529 | Non Small Cell Lung Cancer | Adenocarcinoma | NA | FACs followed by SFA | 0.2 | 0.211 | 28855609 |
| ITGB1 | 6153 | Non Small Cell Lung Cancer | NA | NA | FACs | 0.2 | 0.018 | 19464919 |
| ITGB4 | 6158 | Non Small Cell Lung Cancer | NA | NA | SFA followed by FACs | 0.2 | 0.0074 | 28416482 |
| KIT | 6342 | Lung Cancer | Adenocarcinoma | NA | SFA and Tumorigenicity assay followed by FACs | 0.2 | 0.018 | 25034785 |
| KIT | 6342 | Lung Cancer | Squamous Cell Carcinoma | NA | SFA and Tumorigenicity assay followed by FACs | 0.2 | 0.018 | 25034785 |
| LGR6 | 19719 | Lung Cancer | Adenocarcinoma | NA | FACs followed by CFA and Tumorigenicity assay | 0.2 | 0.0042 | 27197183 |
| PLAUR | 9053 | Lung Cancer | NA | NA | FACs | 0.2 | 0.0085 | 19536353 |